Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 687

1.

microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus.

Sethuraman S, Gay LA, Jain V, Haecker I, Renne R.

PLoS Pathog. 2017 Jul 17;13(7):e1006508. doi: 10.1371/journal.ppat.1006508. eCollection 2017 Jul.

2.

NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency.

Ma Z, Hopcraft SE, Yang F, Petrucelli A, Guo H, Ting JP, Dittmer DP, Damania B.

PLoS Pathog. 2017 May 1;13(5):e1006350. doi: 10.1371/journal.ppat.1006350. eCollection 2017 May.

3.

Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.

Sanchez EL, Pulliam TH, Dimaio TA, Thalhofer AB, Delgado T, Lagunoff M.

J Virol. 2017 Apr 28;91(10). pii: e02237-16. doi: 10.1128/JVI.02237-16. Print 2017 May 15.

4.

Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues.

Sun R, Tan X, Wang X, Wang X, Yang L, Robertson ES, Lan K.

PLoS Pathog. 2017 Jan 24;13(1):e1006167. doi: 10.1371/journal.ppat.1006167. eCollection 2017 Jan.

5.

Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency.

Wang C, Zhu C, Wei F, Gao S, Zhang L, Li Y, Feng Y, Tong Y, Xu J, Wang B, Yuan Z, Robertson ES, Cai Q.

PLoS Pathog. 2017 Jan 18;13(1):e1006124. doi: 10.1371/journal.ppat.1006124. eCollection 2017 Jan.

6.

Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus.

Schifano JM, Corcoran K, Kelkar H, Dittmer DP.

J Virol. 2017 Jan 31;91(4). pii: e01698-16. doi: 10.1128/JVI.01698-16. Print 2017 Feb 15.

7.

Changes in relative and absolute concentrations of plasma phospholipid fatty acids observed in a randomized trial of Omega-3 fatty acids supplementation in Uganda.

Song X, Diep P, Schenk JM, Casper C, Orem J, Makhoul Z, Lampe JW, Neuhouser ML.

Prostaglandins Leukot Essent Fatty Acids. 2016 Nov;114:11-16. doi: 10.1016/j.plefa.2016.09.002. Epub 2016 Sep 30.

8.

Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.

Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Peer CJ, Bevans M, Sereti I, Maldarelli F, Whitby D, Marshall V, Goncalves PH, Khetani V, Figg WD, Steinberg SM, Zeldis JB, Yarchoan R.

J Clin Oncol. 2016 Dec;34(34):4125-4131. Epub 2016 Oct 31.

9.

Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.

Chandrasekharan JA, Huang XM, Hwang AC, Sharma-Walia N.

J Virol. 2016 Nov 28;90(24):11020-11031. Print 2016 Dec 15.

10.

Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Dittmer DP, Damania B.

J Clin Invest. 2016 Sep 1;126(9):3165-75. doi: 10.1172/JCI84418. Epub 2016 Sep 1. Review.

11.

Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.

Yanik EL, Achenbach CJ, Gopal S, Coghill AE, Cole SR, Eron JJ, Moore RD, Mathews WC, Drozd DR, Hamdan A, Ballestas ME, Engels EA.

J Clin Oncol. 2016 Sep 20;34(27):3276-83. doi: 10.1200/JCO.2016.67.6999. Epub 2016 Aug 9.

12.

Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.

Roy A, Dutta D, Iqbal J, Pisano G, Gjyshi O, Ansari MA, Kumar B, Chandran B.

J Virol. 2016 Sep 12;90(19):8822-41. doi: 10.1128/JVI.01003-16. Print 2016 Oct 1.

13.

KSHV-Mediated Angiogenesis in Tumor Progression.

Purushothaman P, Uppal T, Sarkar R, Verma SC.

Viruses. 2016 Jul 20;8(7). pii: E198. doi: 10.3390/v8070198. Review.

14.

HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.

Yan Q, Shen C, Qin J, Li W, Hu M, Lu H, Qin D, Zhu J, Gao SJ, Lu C.

J Virol. 2016 Sep 12;90(19):8739-53. doi: 10.1128/JVI.00797-16. Print 2016 Oct 1.

15.

Activation of cellular metabolism during latent Kaposi's Sarcoma herpesvirus infection.

Lagunoff M.

Curr Opin Virol. 2016 Aug;19:45-9. doi: 10.1016/j.coviro.2016.06.012. Epub 2016 Jul 18. Review.

16.

Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8.

Sun Z, Jha HC, Pei YG, Robertson ES.

J Virol. 2016 Aug 26;90(18):8047-58. doi: 10.1128/JVI.01079-16. Print 2016 Sep 15.

17.

The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Augments Viral Lytic Replication.

Zhang Z, Chen W, Sanders MK, Brulois KF, Dittmer DP, Damania B.

J Virol. 2016 Aug 12;90(17):7657-66. doi: 10.1128/JVI.03102-15. Print 2016 Sep 1.

18.

Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.

Cheng F, He M, Jung JU, Lu C, Gao SJ.

J Virol. 2016 Jun 24;90(14):6515-25. doi: 10.1128/JVI.00624-16. Print 2016 Jul 15.

19.

The SH3BGR/STAT3 Pathway Regulates Cell Migration and Angiogenesis Induced by a Gammaherpesvirus MicroRNA.

Li W, Yan Q, Ding X, Shen C, Hu M, Zhu Y, Qin D, Lu H, Krueger BJ, Renne R, Gao SJ, Lu C.

PLoS Pathog. 2016 Apr 29;12(4):e1005605. doi: 10.1371/journal.ppat.1005605. eCollection 2016 Apr.

20.

Discovery of a Coregulatory Interaction between Kaposi's Sarcoma-Associated Herpesvirus ORF45 and the Viral Protein Kinase ORF36.

Avey D, Tepper S, Pifer B, Bahga A, Williams H, Gillen J, Li W, Ogden S, Zhu F.

J Virol. 2016 Jun 10;90(13):5953-64. doi: 10.1128/JVI.00516-16. Print 2016 Jul 1. Erratum in: J Virol. 2017 Nov 14;91(23 ):.

Supplemental Content

Loading ...
Support Center